George A. Joulwan, Director at Emergent BioSolutions Inc. (EBS), sold 8,116 shares at $68.45 ($556K) on 2018-11-06, disclosed to the SEC on 2018-11-08.
Open-market sale of $556k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.45 | 4,058 | $278K | 50.0% |
| 2 | $68.45 | 4,058 | $278K | 50.0% |
| Total | $68.45 avg | 8,116 | $556K | 100% |
| Filing → |
| EBS | SELL | 2018-06-12 | $264K | — | Filing → |
| EBS | SELL | 2017-11-09 | $1.2M | — | Filing → |
| EBS | SELL | 2016-06-07 | $207K | — | Filing → |